Patents by Inventor Joseph Glajch

Joseph Glajch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10266590
    Abstract: The present invention relates to the characterization and production of biologics.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: April 23, 2019
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Brian Edward Collins, Joseph Glajch, John Robblee
  • Publication number: 20170152319
    Abstract: The present invention relates to the characterization and production of biosimilars.
    Type: Application
    Filed: September 1, 2016
    Publication date: June 1, 2017
    Inventors: Brian Edward Collins, Joseph Glajch, John Robblee
  • Publication number: 20170074890
    Abstract: The present invention relates to the characterization and production of biologics.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 16, 2017
    Inventors: Brian Edward Collins, Joseph Glajch, John Robblee
  • Publication number: 20140045740
    Abstract: The present disclosure relates to methods for assessing molecular weight characteristics of glatiramer acetate using SEC-MALS.
    Type: Application
    Filed: August 12, 2013
    Publication date: February 13, 2014
    Applicant: Momenta Pharmaceuticals, Inc.
    Inventors: Joseph Glajch, Ying Li